FAIR VALUE MEASUREMENTS

12 Months Ended

Dec. 31, 2024

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

NOTE 3 – FAIR VALUE MEASUREMENTS

As of December 31, 2024 and 2023, the carrying amounts of accounts payable, accounts receivable and other receivables approximate their fair values due to the short-term maturities of these instruments.

The carrying amount of the long-term deposit approximates its fair value since it is measured at its present value applying prevailing interest rates, see note 7.

The Company’s financial assets subject to fair value measurements on a recurring basis and the level of inputs used in such measurements were as follows:

	As of December 31, 2024 ($ in thousands)
	Total		Level 1		Level 2		Level 3
Assets:
Cash equivalents-
Money market funds	$	6,281	$	6,281	$	-	$	-
Marketable securities-
U.S government bonds	$	15,721	$	-	$	15,721	$	-

	As of December 31, 2023 ($ in thousands)
	Total		Level 1		Level 2		Level 3
Assets:
Cash equivalents-
Money market funds	$	7,094	$	7,094	$	-	$	-
Marketable securities-
U.S. government bonds	$	29,383	$	-	$	29,383	$	-

The Company’s debt securities are classified within Level 1 and Level 2 because it uses quoted market prices or alternative pricing sources and models utilizing market observable inputs to determine their fair value.

The cost of marketable securities as of December 31, 2024 and 2023 is $15,277 and 28,727 thousand, respectively.

INSPIREMD, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (continued)